Cell Transplant in Spinal Cord Injury Patients

Status Completed

Clinical Trial Summary

This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00816803
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	May 2005
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04074616` - Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation	N/A
Completed	`NCT05284201` - LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury	N/A
Completed	`NCT03458871` - Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation	N/A
Active, not recruiting	`NCT02136823` - Impact of Persistent Conductances on Motor Unit Firing in SCI	N/A
Completed	`NCT03989440` - AXER-204 in Participants With Chronic Spinal Cord Injury	Phase 1/Phase 2
Completed	`NCT04697472` - The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury	N/A
Recruiting	`NCT05644171` - RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation	N/A
Recruiting	`NCT05965700` - NVG-291 in Spinal Cord Injury Subjects	Phase 1/Phase 2